GATT and Patent Extensions
The controversy over GATT patent extensions continues to be legally messy and the ultimate outcome is unclear, with contests looming or likely to loom over recent FDA and PTO rulings as well as the wording of certain stipulations in GATT.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.